Partial cytogenetic response with toceranib and prednisone treatment in a young dog with chronic monocytic leukemia.
Anticancer Drugs
; 24(10): 1098-103, 2013 Nov.
Article
in En
| MEDLINE
| ID: mdl-23995854
ABSTRACT
Treatment of chronic monocytic leukemia (CMoL) in dogs has traditionally consisted of hydroxyurea. The use of tyrosine kinase inhibitors has been proposed as a treatment option for dogs with CMoL but has never been reported. We report a case of CMoL in a young dog that achieved clinical remission with treatment with the tyrosine kinase inhibitor toceranib and prednisone.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Leukemia, Myeloid
/
Fusion Proteins, bcr-abl
/
Dog Diseases
Limits:
Animals
Language:
En
Journal:
Anticancer Drugs
Journal subject:
ANTINEOPLASICOS
Year:
2013
Type:
Article
Affiliation country:
United States